在冠状动脉疾病与冠状动脉微血管功能障碍的辅助阿育吠陀管理
1Manjushree Research Institute of Ayurvedic Science; Gujarat Ayurved University; panchakarma@mrias.co.in.
Journal of visualized experiments : JoVE
|October 6, 2025
概括
阿育吠陀治疗,包括潘卡卡玛和口服药物,有效地管理了冠状动脉微血管功能障碍和冠状动脉疾病患者的疼痛,和失眠. 这种综合性方法补充了现代医学,显示出显著的症状改善.
科学领域:
- 综合性心脏病学 综合性心脏病学
- 艾尔韦达医学是一种医药.
- 心血管健康 心血管健康
背景情况:
- 一个案例研究涉及一个59岁的肥胖,高血压的女性,十年来患有冠状动脉微血管功能障碍 (CMVD) 和冠状动脉疾病 (CAD).
- 患者出现了身体疼痛,左脚疼痛和失眠的症状,在阿育吠陀原则上被诊断为Vataj Hridroga.
研究的目的:
- 评估综合阿育吠陀和现代医学方法的有效性,以管理CMVD和CAD患者的相关症状.
- 突出阿尤尔韦达干预的作用,作为常规治疗的辅助.
主要方法:
- 14天的住院阿育吠陀治疗,包括潘查卡玛疗法 (阿布扬加,纳迪斯维达纳,希罗达拉) 和16周的门诊口服阿育吠陀药物治疗.
- 同时使用现有的现代医疗处方,由阿育吠陀和传统医生密切监督.
主要成果:
- 腿部疼痛显著减少 (在第16天从6降至1日,在第16周消失),第二级胀在第16天消失.
- 失眠的改善,匹兹堡睡眠质量指数分数在第16天和第26周从16/21下降到9/21
- 证明了阿育吠陀疗法与现代医疗管理的成功整合.
结论:
- 艾尔维达干预可以作为一种有效的辅助疗法,用于管理与CMVD和CAD相关的症状.
- 艾尔维达潘卡卡玛和口腔治疗与当代医学的战略整合对复杂心脏病患者来说是有前途的.
- 需要进一步的研究来了解机制,并确认这种综合性协议在心脏疾病中的有效性.
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
01:26Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
01:26Coronary Artery Disease IV: Preventive Measures
589
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
589
01:21Rheumatic Heart Disease III: Medical Management
285
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
285
01:27Peripheral Artery Disease III: Interprofessional Care
242
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
242
01:26Angina IV: Management
236
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
236